Rate of disease burden from drug use disorders who in Afghanistan
Afghanistan: Rate of disease burden from drug use disorders who was 176.8 in 2021. ▲ Rising
Rate of disease burden from drug use disorders who in Afghanistan, 2000–2021
Source: Our World in Data.
Analysis
Afghanistan recorded 176.8 for rate of disease burden from drug use disorders who in 2021. That is the highest value across all 22 years on record.
Compared with earlier readings it is up 3.1% on the previous year and up 4.0% over ten years.
Over the whole period, rate of disease burden from drug use disorders who in Afghanistan peaked at 176.8 in 2021 and was at its lowest, 149.92, in 2000.
Afghanistan ranks 38th of 194 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 22 years of available data.
Rate of disease burden from drug use disorders who in Afghanistan, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 149.92 | — |
| 2001 | 152.49 | +1.7% |
| 2002 | 154.87 | +1.6% |
| 2003 | 159.93 | +3.3% |
| 2004 | 164.5 | +2.9% |
| 2005 | 167.28 | +1.7% |
| 2006 | 168.83 | +0.9% |
| 2007 | 166.73 | -1.2% |
| 2008 | 164.79 | -1.2% |
| 2009 | 164.33 | -0.3% |
| 2010 | 165.25 | +0.6% |
| 2011 | 170 | +2.9% |
| 2012 | 173.07 | +1.8% |
| 2013 | 174.92 | +1.1% |
| 2014 | 176.46 | +0.9% |
| 2015 | 176.43 | -0.0% |
| 2016 | 174.95 | -0.8% |
| 2017 | 173.78 | -0.7% |
| 2018 | 171.48 | -1.3% |
| 2019 | 170.63 | -0.5% |
| 2020 | 171.51 | +0.5% |
| 2021 | 176.8 | +3.1% |
Afghanistan compared with similar countries
- Afghanistan's 176.8 is above the median for low income countries, which is 56.28, 3.1× the median. (25 countries reporting)
- Afghanistan's 176.8 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 132.16, 1.3× the median. (22 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 161.37 | 149.92 | 168.83 | 10 |
| 2010s | 172.7 | 165.25 | 176.46 | 10 |
| 2020s | 174.16 | 171.51 | 176.8 | 2 |
Countries ranked near Afghanistan
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Un projection of annual infant deaths 14,735 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 19 (2025)
- Population ages 00-04, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.75 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, male, per capita 0.0804 units per person (2025)
Frequently asked questions
- What is rate of disease burden from drug use disorders who in Afghanistan?
- Rate of disease burden from drug use disorders who in Afghanistan was 176.8 in 2021, according to Our World in Data.
- What is the highest rate of disease burden from drug use disorders who recorded in Afghanistan?
- The highest recorded value was 176.8 in 2021.
- What is the lowest rate of disease burden from drug use disorders who recorded in Afghanistan?
- The lowest recorded value was 149.92 in 2000.
- How does Afghanistan rank for rate of disease burden from drug use disorders who?
- Afghanistan ranks 38th out of 194 countries with data for 2021.
- Is rate of disease burden from drug use disorders who rising or falling in Afghanistan?
- Over the last ten years it is up 4.0%. The long-run trend across the full record is rising.
- Where does this Afghanistan data come from?
- The figures come from Our World in Data, published as part of Rate of disease burden from drug use disorders who. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (Our World in Data).